A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus
- Author
- FURIE, Richard1 ; PETRI, Michelle2 ; STOHL, William11 ; GINZLER, Ellen M12 ; HOUGH, Douglas R13 ; ZHONG, Z. John13 ; FREIMUTH, William13 ; VAN VOLLENHOVEN, Ronald F14 ; ZAMANI, Omid3 ; CERVERA, Ricard4 ; WALLACE, Daniel J5 ; TEGZOVA, Dana6 ; SANCHEZ-GUERRERO, Jorge7 ; SCHWARTING, Andreas8 ; MERRILL, Joan T9 ; CHATHAM, W. Winn10
[1] North Shore―Long Island Jewish Health System, Lake Success, New York, United States
[2] Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
[3] Rheumazentrum Favoriten, Vienna, Austria
[4] Hospital Clinic, Barcelona, Spain
[5] Cedars-Sinai Medical Center/David Geffen School of Medicine at University of California, Los Angeles, United States
[6] Charles University, Prague, Czech Republic
[7] Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubrián, Delegacion Tlalpan, Mexico
[8] Universitatsklinik Mainz, Mainz, Germany, and Sana-Rheumazentrum Rheinland-Pfalz AG, Bad Kreuznach, Germany
[9] Oklahoma Medical Research Foundation, Oklahoma City, United States
[10] University of Alabama, Birmingham, United States
[11] Los Angeles County and University of Southern California Medical Center and University of Southern California Keck School of Medicine, Los Angeles, United States
[12] State University of New York Downstate Medical Center, Brooklyn, United States
[13] Human Genome Sciences, Rockville, Maryland, United States
[14] Karolinska Institute, Stockholm, Sweden - Source
Arthritis and rheumatism. 2011, Vol 63, Num 12, pp 3918-3930, 13 p ; ref : 34 ref
- CODEN
- ARHEAW
- ISSN
- 0004-3591
- Scientific domain
- Rheumatology
- Publisher
- Wiley, Hoboken , NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticorps monoclonal Bélimumab Essai clinique phase III Homme Immunomodulateur Lupus érythémateux disséminé Lymphocyte B Rhumatologie Immunopathologie Maladie autoimmune Maladie de système Pathologie de la peau Pathologie du tissu conjonctif
- Keyword (en)
- Monoclonal antibody Belimumab Phase III trial Human Immunomodulator Systemic lupus erythematosus B-Lymphocyte Rheumatology Immunopathology Autoimmune disease Systemic disease Skin disease Connective tissue disease
- Keyword (es)
- Anticuerpo monoclonal Belimumab Ensayo clínico fase III Hombre Inmunomodulador Lupus eritematoso sistémico Linfocito B Reumatología Inmunopatología Enfermedad autoinmune Enfermedad sistémica Piel patología Tejido conjuntivo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B07 Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system
- Discipline
- Osteoarticular pathology Pharmacological treatments Sarcoidosis. Granulomatosis of undetermined origin. Connective tissue diseases. Vasculitides
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25330704
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/art.30613 
https://dx.doi.org/10.1002/art.30613
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.30613\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3918\";s:8:\"\u0000*\u0000epage\";s:4:\"3930\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"FURIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Richard\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PETRI, Michelle\";i:1;s:14:\"STOHL, William\";i:2;s:16:\"GINZLER, Ellen M\";i:3;s:16:\"HOUGH, Douglas R\";i:4;s:14:\"ZHONG, Z. John\";i:5;s:17:\"FREIMUTH, William\";i:6;s:25:\"VAN VOLLENHOVEN, Ronald F\";i:7;s:12:\"ZAMANI, Omid\";i:8;s:15:\"CERVERA, Ricard\";i:9;s:17:\"WALLACE, Daniel J\";i:10;s:13:\"TEGZOVA, Dana\";i:11;s:23:\"SANCHEZ-GUERRERO, Jorge\";i:12;s:19:\"SCHWARTING, Andreas\";i:13;s:15:\"MERRILL, Joan T\";i:14;s:16:\"CHATHAM, W. Winn\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.30613\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3918\";s:8:\"\u0000*\u0000epage\";s:4:\"3930\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"FURIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Richard\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PETRI, Michelle\";i:1;s:14:\"STOHL, William\";i:2;s:16:\"GINZLER, Ellen M\";i:3;s:16:\"HOUGH, Douglas R\";i:4;s:14:\"ZHONG, Z. John\";i:5;s:17:\"FREIMUTH, William\";i:6;s:25:\"VAN VOLLENHOVEN, Ronald F\";i:7;s:12:\"ZAMANI, Omid\";i:8;s:15:\"CERVERA, Ricard\";i:9;s:17:\"WALLACE, Daniel J\";i:10;s:13:\"TEGZOVA, Dana\";i:11;s:23:\"SANCHEZ-GUERRERO, Jorge\";i:12;s:19:\"SCHWARTING, Andreas\";i:13;s:15:\"MERRILL, Joan T\";i:14;s:16:\"CHATHAM, W. Winn\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.30613\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.30613\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3918\";s:8:\"\u0000*\u0000epage\";s:4:\"3930\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"FURIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Richard\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PETRI, Michelle\";i:1;s:14:\"STOHL, William\";i:2;s:16:\"GINZLER, Ellen M\";i:3;s:16:\"HOUGH, Douglas R\";i:4;s:14:\"ZHONG, Z. John\";i:5;s:17:\"FREIMUTH, William\";i:6;s:25:\"VAN VOLLENHOVEN, Ronald F\";i:7;s:12:\"ZAMANI, Omid\";i:8;s:15:\"CERVERA, Ricard\";i:9;s:17:\"WALLACE, Daniel J\";i:10;s:13:\"TEGZOVA, Dana\";i:11;s:23:\"SANCHEZ-GUERRERO, Jorge\";i:12;s:19:\"SCHWARTING, Andreas\";i:13;s:15:\"MERRILL, Joan T\";i:14;s:16:\"CHATHAM, W. Winn\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.30613\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3918\";s:8:\"\u0000*\u0000epage\";s:4:\"3930\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"FURIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Richard\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PETRI, Michelle\";i:1;s:14:\"STOHL, William\";i:2;s:16:\"GINZLER, Ellen M\";i:3;s:16:\"HOUGH, Douglas R\";i:4;s:14:\"ZHONG, Z. John\";i:5;s:17:\"FREIMUTH, William\";i:6;s:25:\"VAN VOLLENHOVEN, Ronald F\";i:7;s:12:\"ZAMANI, Omid\";i:8;s:15:\"CERVERA, Ricard\";i:9;s:17:\"WALLACE, Daniel J\";i:10;s:13:\"TEGZOVA, Dana\";i:11;s:23:\"SANCHEZ-GUERRERO, Jorge\";i:12;s:19:\"SCHWARTING, Andreas\";i:13;s:15:\"MERRILL, Joan T\";i:14;s:16:\"CHATHAM, W. Winn\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.30613\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3918\";s:8:\"\u0000*\u0000epage\";s:4:\"3930\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"FURIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Richard\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:15:\"PETRI, Michelle\";i:1;s:14:\"STOHL, William\";i:2;s:16:\"GINZLER, Ellen M\";i:3;s:16:\"HOUGH, Douglas R\";i:4;s:14:\"ZHONG, Z. John\";i:5;s:17:\"FREIMUTH, William\";i:6;s:25:\"VAN VOLLENHOVEN, Ronald F\";i:7;s:12:\"ZAMANI, Omid\";i:8;s:15:\"CERVERA, Ricard\";i:9;s:17:\"WALLACE, Daniel J\";i:10;s:13:\"TEGZOVA, Dana\";i:11;s:23:\"SANCHEZ-GUERRERO, Jorge\";i:12;s:19:\"SCHWARTING, Andreas\";i:13;s:15:\"MERRILL, Joan T\";i:14;s:16:\"CHATHAM, W. Winn\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
